OPKO Health (MEX:OPK) Cyclically Adjusted Revenue per Share: MXN36.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OPK OPKO Health Inc MEX:OPK
50 GF Score
Price MXN26.20
GF Value MXN19.10
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is OPKO Health Cyclically Adjusted Revenue per Share?

OPKO Health MEX:OPK 50 Cyclically Adjusted Revenue per Share is MXN36.11 as of Mar. 2026. GuruFocus rates MEX:OPK with a GF Score™ of 50/100 and a GF Value™ of MXN19.10 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OPKO Health's adjusted revenue per share for the three months ended in Mar. 2026 was MXN2.951. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN36.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, OPKO Health's average Cyclically Adjusted Revenue Growth Rate was -3.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of OPKO Health was 57.00% per year. The lowest was -3.90% per year. And the median was 23.30% per year.

As of today (2026-07-21), OPKO Health's current stock price is MXN26.20. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN36.11. OPKO Health's Cyclically Adjusted PS Ratio of today is 0.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 29.97. The lowest was 0.48. And the median was 2.18.


OPKO Health  (MEX:OPK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=26.20/36.11
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 29.97. The lowest was 0.48. And the median was 2.18.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OPKO Health Cyclically Adjusted Revenue per Share Related Terms


OPKO Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for OPKO Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Cyclically Adjusted Revenue per Share Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.43 36.67 31.20 44.07 38.12

OPKO Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.25 38.82 32.90 38.12 36.11

MEX:OPK vs PSNL, CDNA, CSTL: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.


MEX:OPK
50GF Score
OPKO Health Inc MEX:OPK
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OPKO Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.951/330.2130*330.2130
=2.951

Current CPI (Mar. 2026) = 330.2130.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 11.856 241.018 16.244
201609 10.435 241.428 14.272
201612 6.124 241.432 8.376
201703 8.982 243.801 12.166
201706 9.375 244.955 12.638
201709 7.982 246.819 10.679
201712 5.651 246.524 7.569
201803 8.278 249.554 10.954
201806 9.260 251.989 12.135
201809 8.347 252.439 10.919
201812 7.592 251.233 9.979
201903 7.359 254.202 9.559
201906 7.416 256.143 9.561
201909 7.703 256.759 9.907
201912 6.794 256.974 8.730
202003 7.741 258.115 9.903
202006 10.853 257.797 13.902
202009 14.759 260.280 18.725
202012 15.357 260.474 19.469
202103 17.389 264.877 21.678
202106 13.611 271.696 16.542
202109 12.170 274.310 14.650
202112 12.624 278.802 14.952
202203 9.927 287.504 11.402
202206 8.749 296.311 9.750
202209 4.818 296.808 5.360
202212 4.806 296.797 5.347
202303 5.698 301.836 6.234
202306 6.053 305.109 6.551
202309 4.139 307.789 4.441
202312 4.106 306.746 4.420
202403 4.078 312.332 4.311
202406 4.787 314.175 5.031
202409 3.424 315.301 3.586
202412 5.657 315.605 5.919
202503 4.568 319.799 4.717
202506 3.747 322.561 3.836
202509 3.567 324.800 3.626
202512 3.489 324.054 3.555
202603 2.951 330.213 2.951

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN36.11 mean?
OPKO Health (MEX:OPK) has a Cyclically Adjusted Revenue per Share of MXN36.11 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OPKO Health and its competitors.
Is OPKO Health's Cyclically Adjusted Revenue per Share too high?
OPKO Health's current Cyclically Adjusted Revenue per Share is MXN36.11. Overall, OPKO Health has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Cyclically Adjusted Revenue per Share compare to PSNL and CDNA?
OPKO Health's Cyclically Adjusted Revenue per Share of MXN36.11 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OPKO Health and its competitors. OPKO Health's current Cyclically Adjusted Revenue per Share is MXN36.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (MEX:OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN19.10, compared to a current price of MXN26.20 — trading 37.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN36.11. OPKO Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For OPKO Health (MEX:OPK), the current Cyclically Adjusted Revenue per Share is MXN36.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (MEX:OPK) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of MXN26.20 is trading 37.2% above its estimated GF Value™ of MXN19.10. GuruFocus considers OPKO Health to be Significantly Overvalued.

Key valuation signals for MEX:OPK:

  • Cyclically Adjusted Revenue per Share: MXN36.11
  • GF Value™: MXN19.10 vs. price of MXN26.20 (37.2% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the MEX:OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
50GF Score

Get the complete analysis for MEX:OPK

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN26.20
Price
MXN19.10
GF Value